Total Payments
$8,092
2024 Payments
$13.31
Companies
34
Transactions
594
Medicare Patients
838
Medicare Billing
$66,097
Payment Breakdown by Category
Food & Beverage$7,973 (98.5%)
Education$119.14 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,973 | 588 | 98.5% |
| Education | $119.14 | 6 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,208 | 106 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,099 | 62 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $940.92 | 67 | $0 (2022) |
| Lilly USA, LLC | $746.24 | 60 | $0 (2022) |
| GlaxoSmithKline, LLC. | $547.41 | 38 | $0 (2022) |
| PFIZER INC. | $470.92 | 44 | $0 (2022) |
| Astellas Pharma US Inc | $369.27 | 21 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $348.12 | 34 | $0 (2021) |
| ABBVIE INC. | $326.10 | 24 | $0 (2022) |
| Merck Sharp & Dohme LLC | $309.54 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.31 | 1 | Novo Nordisk Inc ($13.31) |
| 2022 | $1,028 | 65 | ABBVIE INC. ($212.25) |
| 2021 | $1,556 | 98 | Boehringer Ingelheim Pharmaceuticals, Inc. ($226.44) |
| 2020 | $253.45 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($57.64) |
| 2019 | $1,286 | 94 | Novo Nordisk Inc ($299.35) |
| 2018 | $1,512 | 122 | Novo Nordisk Inc ($278.92) |
| 2017 | $2,443 | 199 | AstraZeneca Pharmaceuticals LP ($454.12) |
All Payment Transactions
594 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes | ||||||
| 08/30/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: DIABETES | ||||||
| 08/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Diabetes | ||||||
| 08/17/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Obesity | ||||||
| 08/15/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/03/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Gastroenterology | ||||||
| 08/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Cardio-renal | ||||||
| 07/22/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Diabetes | ||||||
| 07/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Diabetes Care | ||||||
| 07/12/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Inflammation | ||||||
| 07/11/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/28/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, MOUNJARO | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Diabetes | ||||||
| 06/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Diabetes Care | ||||||
| 06/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: Neuroscience | ||||||
| 06/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: DIABETES | ||||||
| 06/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardio-renal | ||||||
| 06/01/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 150 | 180 | $40,724 | $8,555 |
| 2021 | 9 | 365 | 482 | $94,667 | $40,578 |
| 2020 | 11 | 323 | 368 | $49,863 | $16,964 |
Total Patients
838
Total Services
1,030
Medicare Billing
$66,097
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 120 | $24,480 | $5,477 | 22.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 44 | 44 | $14,036 | $2,448 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $2,208 | $629.60 | 28.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 219 | $44,676 | $19,406 | 43.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 77 | 77 | $24,563 | $9,506 | 38.7% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 20 | 20 | $7,760 | $4,564 | 58.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 36 | $4,968 | $2,152 | 43.3% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 29 | 29 | $5,307 | $1,926 | 36.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 15 | 15 | $2,580 | $1,871 | 72.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 35 | 36 | $2,484 | $596.57 | 24.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 31 | 31 | $2,139 | $513.68 | 24.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 17 | 19 | $190.00 | $42.75 | 22.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 101 | $20,604 | $6,044 | 29.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 26 | 26 | $8,294 | $2,959 | 35.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 38 | 49 | $5,666 | $2,278 | 40.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $3,487 | $1,219 | 34.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 20 | 20 | $1,860 | $1,134 | 61.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 21 | $2,898 | $1,013 | 35.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $2,479 | $991.33 | 40.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 20 | 20 | $1,392 | $524.56 | 37.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 23 | 23 | $1,587 | $363.11 | 22.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 14 | 14 | $966.00 | $229.15 | 23.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 59 | 70 | $630.00 | $207.54 | 32.9% |
About Dr. Allison Medlin, M.D
Dr. Allison Medlin, M.D is a Family Medicine healthcare provider based in Independence, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1508018128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allison Medlin, M.D has received a total of $8,092 in payments from pharmaceutical and medical device companies, with $13.31 received in 2024. These payments were reported across 594 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,973).
As a Medicare-enrolled provider, Medlin has provided services to 838 Medicare beneficiaries, totaling 1,030 services with total Medicare billing of $66,097. Data is available for 3 years (2020–2022), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Independence, MO
- Active Since 10/14/2008
- Last Updated 05/20/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508018128
Products in Payments
- FARXIGA (Drug) $826.95
- TRULICITY (Drug) $504.58
- Ozempic (Drug) $454.30
- JARDIANCE (Drug) $403.08
- Saxenda (Drug) $306.09
- Victoza (Drug) $283.37
- XARELTO (Drug) $254.70
- STIOLTO RESPIMAT (Drug) $238.07
- CHANTIX (Drug) $223.53
- TRADJENTA (Drug) $212.61
- TRELEGY ELLIPTA (Drug) $183.36
- ANORO (Drug) $165.38
- MYRBETRIQ (Drug) $159.73
- SYMBICORT (Drug) $143.66
- ENTRESTO (Drug) $141.19
- JANUVIA (Drug) $133.76
- VRAYLAR (Drug) $124.00
- QULIPTA (Drug) $120.02
- BREZTRI (Drug) $117.51
- ZENPEP (Drug) $116.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Independence
Dr. Anthony Gunn, M.d, M.D
Family Medicine — Payments: $11,015
Family Medicine $11,015
Mark Bowling, Md, MD
Family Medicine — Payments: $10,745
Family Medicine $10,745
Jason Bergman, Md, MD
Family Medicine — Payments: $10,276
Family Medicine $10,276
Jennifer Patterson, M.d, M.D
Family Medicine — Payments: $8,262
Family Medicine $8,262
Dr. James Linnick, D.o, D.O
Family Medicine — Payments: $8,163
Family Medicine $8,163
Dr. Michael Wells, D.o, D.O
Family Medicine — Payments: $7,953
Family Medicine $7,953